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A B S T R A C T
Since almost 20 y it is known that seizures may trigger Takotsubo syndrome (TTS). Since then it has been
repeatedly proposed that TTS could be the cause of sudden unexpected death in epilepsy (SUDEP).
A review of the so far reported cases of seizure-triggered TTS was carried out to see how often seizure-
triggered TTS is fatal.
Altogether 59 papers were identiﬁed which reported altogether 74 patients with seizure-triggered
TTS. Age was reported in 70 patients and ranged from 18 to 82 y. Gender was reported in 70 cases and
was female in 60 cases (86%). The type of triggering seizure was reported in 47 cases. In 28 patients (60%)
the trigger was a generalized tonic clonic seizure, in 15 cases (32%) a generalized status epilepticus, and
in 3 cases a complex partial seizure. The outcome was mentioned in 63 of the 74 patients. Full recovery
was reported in 61 cases (97%), incomplete recovery in none of the patients, and a fatal outcome in 2
patients (3%).
Fatalities are rare in patients experiencing seizure-triggered TTS. This is why seizure-triggered TTS
does not seem to play a major role in the pathogenesis of SUDEP.
 2015 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
Contents lists available at ScienceDirect
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Central nervous system (CNS) disease is increasingly recognized
as a trigger of Takotsubo syndrome (TTS), also known as Tako-tsubo
cardiomyopathy, ampulla cardiomyopathy, apical ballooning,
neurogenic stress cardiomyopathy, broken heart syndrome, neuro-
genic stunned myocardium, transient regional left ventricular
dysfunction, transient myocardial dysfunction, transient systolic
dysfunction, neurogenic stressed myocardium, catecholamine
cardiomyopathy, or reversible acute heart failure [1,2]. TTS mimics
myocardial infarction clinically, electrocardiographically, and
chemically. Clinically, TTS is characterized by acute onset chest
pain and dyspnea, occasionally associated with palpitations,
coughing, edema, tiredness, syncope, fever, nausea, vomiting, or
anxiety [3]. Creatine-kinase (CK), troponin-T, and proBNP may be
elevated. Electrocardiography (ECG) may show initial ST-elevation,
which dynamically changes to negative T-waves, and ﬁnally
complete resolution of the abnormalities [4]. Echocardiography
may show segmental hypokinesia or akinesia and reduced systolic
function and compensatory hyperkinesia of segments not affected
by the stunning. Most frequently, stunning affects the apical or* Corresponding author. Tel.: +43 1 71165 92085; fax: +43 1 4781711.
E-mail address: ﬁﬁgs1@yahoo.de (J. Finsterer).
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1059-1311/ 2015 British Epilepsy Association. Published by Elsevier Ltd. All rights remidventricular segments of the left ventricular myocardium
(classical type), but rarely also the midventricular segments
(midventricular type), the basal or midventricular segments
(inverted type), or all segments (global type) are affected [2].
According to a recent review [3], the CNS disorder most frequently
triggering TTS is subarachnoid bleeding but the CNS disorder second
most frequently triggering TTS is epilepsy [3]. This mini-review
aimed at highlighting recent advances concerning the prevalence,
age at occurrence, gender distribution, TTS type, and outcome of TTS
triggered by epileptic seizures or an epileptic state. Additionally, we
were interested in the cause of epilepsy, the seizure type, and the
antiepileptic drug (AED) therapy prior to the TTS.
2. Methods
Data for this review were retrieved by searches of MedLine and
references from relevant articles using the search terms ‘‘epilepsy’’
and ‘‘seizures’’ combined with ‘‘Takotsubo syndrome’’, ‘‘Takotsubo
cardiomyopathy’’, ‘‘ampulla cardiomyopathy’’, ‘‘stress cardiomy-
opathy’’, ‘‘apical ballooning’’, ‘‘broken heart syndrome’’, and
‘‘stunned myocardium’’. Randomized (blinded or open label)
clinical trials, longitudinal studies, case series, and case reports
were pondered. Only articles published in English between 1966
and 2015 were considered. Appropriate papers were studied and
discussed for their suitability to be incorporated in this review.served.
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Altogether 59 papers matching the search terms were selected.
Full access was available to 47 articles (80%) and 12 papers were
accessible only as an abstract. Fifty-one papers were case reports or
single cases with epilepsy in a cohort study. Eight papers reported
more than 1 patient but none of the papers reported more thanTable 1
Seizures triggering TTS.
Cause of epilepsy ST AED at TTS NOP Sex 
Nm nm nm 5 f 
Nm nm nm 3 nm 
Nm TCS nm 3 f 
Nm SE nm 3 2f, 1 m
Stroke, alcohol, amitryptillin nm nm 3 2f, 1 m
Nm nm nm 2 f 
Nm/psychosis TCS PHT/LEV, CBZ 2 f 
SAB/ICB TCS nm 2 1 m, 1f
Nm nm nm 1 nm 
Nm nm nm 1 f 
Previous stroke nm VPA 1 f 
Bleeding right frontotemporal sTCS PHT, LEV 1 f 
Genetic CPS ZNS, LMT 1 f 
Previous stroke TCS PHT 1 f 
Genetic SE None 1 f 
Alcohol withdrawal nm LEV 1 f 
Genetic TCS CBZ, VPA, PRM 1 f 
Nm TCS None 1 f 
Cryptogenic, left temporal SE VPA, ZNS, DZP 1 f 
Nm TCS, SE CBZ 1 f 
Subarachnoid bleeding TCS None 1 f 
Nm SE LEV, CLB 1 f 
Na SE na 1 f 
Trauma SE nm 1 m 
Alcohol TCS None 1 m 
Genetic TCS None 1 f 
Stroke nm nm 1 m 
Anesthesia NES na 1 f 
Previous stroke TCS None 1 f 
Genetic TCS VPA 1 f 
Na na na 1 f 
Subdural hematoma CPS CBZ 1 m 
Nm TCS None 1 f 
Cavernoma bleeding TCS None 1 f 
Right mesial temporal sclerosis sTCS CBZ, PHT, ZNS,
TPM
1 f 
Alcohol nm None 1 f 
Nm nm nm 1 f 
Cavernoma mesotemporal TCS GBT 1 f 
Na Na na 1 f 
Stroke CPS nm 1 f 
Nm nm nm 1 f 
Opiate withdrawal TCS None 1 f 
PRES SE None 1 f 
Nm nm nm 1 m 
Electroconvulsive therapy TCS None 1 f 
Nm nm nm 1 f 
Ischemic stroke TCS nm 1 f 
Ischemic stroke TCS, SE nm 1 f 
Genetic TCS, SE nm 1 m 
Genetic TCS, SE DZP, PHT, VPA 1 f 
PRES TCS None 1 f 
Mesiotemporal sclerosis TCS, SE CBZ, LEV 1 f 
Genetic TCS CBZ, PHT 1 f 
Multiple sclerosis TCS None 1 f 
Astrocytoma surgery TCS, SE na 1 f 
Alcohol withdrawal na na 1 f 
Genetic TCS None 1 f 
Left frontal hypodensitiy nm nm 1 m 
Nm TCS nm 1 f 
AED, antiepileptic drug; ST, seizure type; NOP, number of patients; TTST, TTS-type; TTST
subarachnoid bleeding; ICB, intracerebral bleeding; PRES, posterior reversible encepha
seizure; SE, status epilepticus; NES, non-epileptic seizure; f, female; m, male; FR, full 
accessible; CLB, clobazam; DZP, diazepam; PHT, phenytoin; CBZ, carbamazepine; VPA, val
TPM, topiramate; BB, beta-blockers; ACEI, angiotensin converting enzyme inhibitors; H5 patients (Table 1). Altogether, 74 patients with epilepsy-
triggered TTS were identiﬁed (Table 1). Among the nine papers
reporting >2 patients, all were accessible as full papers. In the
study with 5 patients nothing is reported about the cause, type, or
treatment of seizures [5]. None of the ﬁve patients experienced
cardiac symptoms prior or during hospitalization [5]. The only
indication for cardiac disease in these 5 patients was elevatedAge TTST TTSTr OC Reference FP/AB
49–78 nm nm FR [5] FP
nm nm nm nm [9] FP
43–80 Classic nm FR [10] FP
 18–47 Global nm nm [11] FP
 40–73 nm nm FR [6] FP
41 + 78 Classic nm FR [12] FP
63/50 Classic BB, ACEI FR [13] FP
 50 + 62 Mid HFT FR [14] FP
nm nm nm nm [15] AB
73 Classic None FR [16] FP
68 Classic nm na [17] AB
55 Classic Stent FR [18] FP
19 nm None nm [7] FP
44 Classic ACEI FR [19] FP
47 Classic nm FR [20] FP
57 Classic HFT FR [21] FP
67 Classic None FR [22] FP
50 Classic BB, ACEI FR [23] FP
43 Classic None FR [24] FP
68 Classic None FR [25] FP
60 Classic None FR [26] FP
79 Classic None FR [27] FP
50 Classic nm FR [28] AB
50 Classic None FR [29] FP
63 Classic None FR [30] FP
69 Classic nm FR [31] AB
78 Classic nm Death [32] FP
67 Mid nm FR [33] AB
67 Classic None FR [34] FP
81 Classic nm FR [35] FP
59 nm nm nm [36] AB
73 nm nm nm [37] AB
50 Classic nm FR [38] AB
74 Classic None FR [39] FP
51 Classic None FR [40] FP
25 Classic nm FR [41] AB
75 MId nm nm [42] FP
71 Classic None Death [43] FP
42 Mid nm FR [44] AB
75 Classic nm FR [45] FP
79 Classic nm FR [46] FP
58 Classic BB FR [47] FP
82 Classic None FR [48] FP
57 Classic Dobutamine FR [49] FP
71 Classic None FR [50] FP
77 Mid nm FR [51] FP
62 Classic ACEI, DR FR [52] FP
54 Classic ACEI, DR FR [53] FP
62 Mid None FR [54] FP
75 Classic Nitro FR [55] FP
55 Classic None FR [56] FP
61 Classic BB, DR FR [57] FP
64 Classic BB, DR FR [58] FP
69 Classic None FR [59] FP
59 Classic nm FR [60] AB
49 Classic nm FR [61] AB
82 Classic None FR [62] FP
39 Inverted nm FR [63] FP
67 Classic nm FR [64] FP
r, treatment of TTS; OC, outcome; FP/AB, full paper or only abstract available; SAB,
lopathy syndrome; CPS, complex partial seizures; (s)TCS, (secondary) tonic clonic
recovery; IR, incomplete recovery; *, epileptic state; nm, not mentrioned; na, not
proic acid; LEV, levetirazetam; LMT, lamotrigine; ZNS, zonisamide; PRM, primidone;
FT, heart failure therapy; DR, diuretics.
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revealing TTS. The ﬁrst paper about seizure-triggered TTS was
provided by Sharkey et al. in 1998. In a series of 22 patients with
TTS, three had generalized seizures prior to the development of TTS
[6]. Two of them were female, age ranged between 40 and 73 y, and
all had a favorable outcome. Unfortunately, no information about
the cause and treatment of epilepsy and the TTS type were
provided [6]. Among all 74 patients with seizure-triggered TTS so
far reported, age was reported in 70 patients, ranging from 18 to
82 y. Gender was reported in 70 cases and was female in 60 (86%)
and male in 10 (14%) cases. The type of triggering seizure was
reported in 47 cases. In 28 patients (60%) the trigger was a
generalized tonic clonic seizure (TCS), in 15 cases (32%) a
generalized status epilepticus, and in 3 cases a complex partial
seizure (Table 1). Data about the antiepileptic medication prior to
TTS were provided for 18 patients. In some studies it was unclear if
the given AED was taken already prior to TTS or prescribed after the
triggering seizure. The type of TTS was reported in 59 patients, of
which 48 (81%) presented with the classical type, 7 with the
midventricular type, 1 with the inverted (inverse) type, and 3 with
the global type (Table 1). Treatment for TTS was given in 15 cases
(Table 1). No treatment for TTS was provided in 19 cases. Only 1 of
those who received no treatment died. The outcome was reported
in 63 of the 74 patients so far published. Full recovery of TTS was
reported in 61 cases (97%), incomplete recovery in none of the
patients, and a fatal outcome in 2 patients (3%).
4. Discussion
This mini-review shows that TTS is increasingly recognized as a
possible complication of generalized seizures. Diagnosing TTS in
patients after a seizure is essential since treatment of TTS may
improve the outcome of affected patients. However, of the 19
patients who did not receive treatment only one died and of the 14
patients who received treatment, none died. Though it is
speculated that TTS is one possible mechanism to explain sudden
unexpected death in epilepsy (SUDEP), the present review argues
against a strong causal relation. Only 3% of the patients with
seizure-triggered TTS died during or after the event. In 97% of the
cases the outcome of seizure-triggered TTS was favorable,
irrespective if TTS was treated or not, suggesting that TTS without
complications is not responsible for SUDEP in a signiﬁcant number
of cases. Only if TTS is complicated by non-sustained ventricular
arrhythmias or asystole it is conceivable that TTS secondarily
causes SUDEP. More frequently than uncomplicated TTS, ventric-
ular arrhythmias or a pulmonary complication may cause SUDEP. A
further argument against a strong role of TTS in the pathomechan-
ism of SUDEP is that TTS generally carries a favorable outcome,
disregarding the underlying trigger. Only in patients with
subarachnoid bleeding the outcome of TTS is fatal in 34%, and
thus higher compared to patients with seizure-triggered TTS,
possibly due to the increased mortality of the underlying
neurologic disease.
In conclusion this minireview shows that seizure-triggered
TTS has been reported in 74 cases since its ﬁrst description in
1998 [6]. No information about the prevalence of TTS among
epilepsy patients has been provided so far. Age at occurrence of
TTS ranges from 18 to 82 y [7,8]. There is a striking female
preponderance. All types of TTS may be triggered by seizures but
the classical type prevails. The outcome is favorable in 97% of the
cases, irrespective of treating or not treating TTS, making it rather
unlikely that TTS plays a strong role in the pathomechanism of
SUDEP. It appears that patients with generalized seizures do not
need to receive beta-blockers for prophylactic reasons to prevent
TTS.Financial disclosure statement
Dr. Finsterer and Dr. Bersano report no disclosures.
Conﬂict of interest statement
The authors declare that there are no conﬂicts of interest.
References
[1] Pelliccia F, Greco C, Vitale C, Rosano G, Gaudio C, Kaski JC. Takotsubo syndrome
(stress cardiomyopathy): an intriguing clinical condition in search of its
identity. Am J Med 2014;(April). http://dx.doi.org/10.1016/j.amjmed.2014.
04.004 [pii: S0002-9343(14)00309-X].
[2] Yoshikawa T. Takotsubo cardiomyopathy, a new concept of cardiomyopathy:
clinical features and pathophysiology. Int J Cardiol 2015;182:297–303.
[3] Finsterer J, Wahbi K. CNS disease triggering Takotsubo stress cardiomyopathy.
Int J Cardiol 2014;177:322–9.
[4] Madias JE. Seizure-related Takotsubo syndrome: a need to upgrade its work-
up and therapy. Int J Cardiol 2015;181:46–7.
[5] Schneider F, Kadel C, Pagitz M, Sen S. Takotsubo cardiomyopathy and elevated
troponin levels following cerebral seizure. Int J Cardiol 2010;145:586–7.
[6] Sharkey SW, Shear W, Hodges M, Herzog CA. Reversible myocardial contrac-
tion abnormalities in patients with an acute noncardiac illness. Chest
1998;114:98–105.
[7] Hashimoto M, Nakajima M, Kuroda R, Yamaguchi R, Maeda H, Nagai H, et al.
Sudden unexpected death in a patient with epilepsy presenting with high
N-terminal probrain natriuretic peptide level, cardiac lesions, and pulmonary
edema. Int J Cardiol 2014;172:e265–7.
[8] Fugate JE, Wijdicks EF, Kumar G, Rabinstein AA. One thing leads to another:
GBS complicated by PRES and Takotsubo cardiomyopathy. Neurocrit Care
2009;11:395–7.
[9] Tsuchihashi K, Ueshima K, Uchida T, Oh-mura N, Kimura K, Owa M, et al.
Transient left ventricular apical ballooning without coronary artery stenosis: a
novel heart syndrome mimicking acute myocardial infarction. Angina pec-
toris–myocardial infarction investigations in Japan. J Am Coll Cardiol
2001;38:11–8.
[10] Le Ven F, Pennec PY, Timsit S, Blanc JJ. Takotsubo syndrome associated with
seizures: an underestimated cause of sudden death in epilepsy? Int J Cardiol
2011;146:475–9.
[11] Hocker S, Prasad A, Rabinstein AA. Cardiac injury in refractory status epilep-
ticus. Epilepsia 2013;54:518–22.
[12] Kurisu S, Inoue I, Kawagoe T, et al. Assessment of medications in patients with
tako-tsubo cardiomyopathy. Int J Cardiol 2009;134:e120–3.
[13] Lemke DM, Hussain SI, Wolfe TJ, et al. Takotsubo cardiomyopathy associated
with seizures. Neurocrit Care 2008;9:112–7.
[14] Chin PS, Branch KR, Becker KJ. Postictal neurogenic stunned myocardium.
Neurology 2005;64:1977–8.
[15] Al-Najaﬁ S, Rosman H. Seizure-induced myocardial stunning: a possible
cardiac link to sudden unexpected death in epilepsy (SUDEP). Seizure
2015;24:137–9.
[16] Han L, Cui L, Yin L, Zhou C. Takotsubo cardiomyopathy induced by epileptic
seizure. Int J Cardiol 2014;177:e145–6.
[17] Kato K, Asami M, Wanifuchi H. Symptomatic seizure associated with takot-
subo cardiomyopathy: a case report. No Shinkei Geka 2014;42:1039–43.
[18] Garea Garcia-Malvar MJ, Gonzalez-Silva Y, Epureanu-Epureanu V. Epileptic
seizures complicated by Takotsubo syndrome. Rev Neurol 2014;59:407–10.
[19] Rocha J, Gonc¸alves E, Vieira C, Almeida F, Pereira J. Takotsubo cardiomyopathy:
a rare, but serious, complication of epileptic seizures. Arq Neuropsiquiatr
2013;71:195–7.
[20] Finsterer J, Sto¨llberger C, Avanzini M, Bastovansky A, Keller H. Aborted sudden
unexplained death in epilepsy in a neuromuscular disorder leading to Takot-
subo syndrome. Int J Cardiol 2013;168:e145–7.
[21] Yazdan-Ashoori P, Nichols R, Baranchuk A. Tako-tsubo cardiomyopathy pre-
cipitated by alcohol withdrawal. Cardiol J 2012;19:81–5.
[22] Cunnington C, Garg S, Balachandran KP. Seizure-associated takotsubo cardio-
myopathy presenting with unheralded ventricular ﬁbrillation. Int J Cardiol
2012;162:e21–3.
[23] Dupuis M, van Rijckevorsel K, Evrard F, Dubuisson N, Dupuis F, Van Robays P.
Takotsubo syndrome (TKS): a possible mechanism of sudden unexplained
death in epilepsy (SUDEP). Seizure 2012;21:51–4.
[24] Rodrı´guez de Antonio LA, Aguilar-Amat Prior MJ, Iva´n˜ez-Mora V, Dı´ez-Tejedor
E. Takotsubo cardiomyopathy as a complication of an epileptic status. Rev
Neurol 2011;53:673–6.
[25] Wakabayashi K, Dohi T, Daida H. Takotsubo cardiomyopathy associated with
epilepsy complicated with giant thrombus. Int J Cardiol 2011;148:e28–30.
[26] Naganuma M, Isoda K, Ishizaki M, Ito K, Hirano T, Uchino M. Epilepsy and
takotsubo cardiomyopathy: a case report. Intern Med 2011;50:2397–9.
[27] Benyounes N, Obadia M, Devys JM, Thevenin A, Iglesias S. Partial status
epilepticus causing a transient left ventricular apical ballooning. Seizure
2011;20:184–6.
[28] Mrejen-Shakin K, Lopez R, Shenoy MM. Life-threatening Takotsubo cardio-
myopathy. Am Heart Hosp J 2011;9:119–21.
J. Finsterer, A. Bersano / Seizure 31 (2015) 84–87 87[29] Traulle´ S, Kubala M, Jarry G, Leborgne L, Hermida JS. Tako-Tsubo syndrome
following status epilepticus. Neurol India 2011;59:480–2.
[30] Sto¨llberger C, Fischer H, Pratter A, Finsterer J. Seizure-induced Takotsubo
cardiomyopathy and thrombocytopenia. Eur J Neurol 2011;18:e68–9.
[31] Yaguchi M, Yaguchi H, Takahashi N. A case of asymptomatic takotsubo
cardiomyopathy with intraventricular thrombus associated with epileptic
seizure. Brain Nerve 2011;63:897–900.
[32] Kurisu S, Inoue I, Kawagoe T, et al. Presentation of Tako-tsubo cardiomyopathy
in men and women. Clin Cardiol 2010;33:42–5.
[33] Shin SW, Baek SH, Choi BS, Lee HJ, Kim KH, Kim ES. Takotsubo cardiomyopathy
associated with nonepileptic seizure after percutaneous endoscopic lumbar
discectomy under general anesthesia. J Anesth 2010;24:460–3.
[34] Rossi P, Bernard F, Aissi K, Bonello L, Demoux AL, Bagneres D, et al. Takotsubo
cardiomyopathy after seizure. BMJ Case Rep 2010;(May). http://dx.doi.org/
10.1136/bcr.11.2009.2492 [pii: bcr1120092492].
[35] Zissimopoulou S, Gianelli S, Schindler T, Perrenoud J. Takotsubo cardiomyop-
athy associated with seizures in asymptomatic geriatric patient. Eur Geriatr
Med 2010;1:99–100.
[36] Alshakarchi J, Lindahl B. Elevated troponin level and acute heart failure in
epileptic attack. Lakartidningen 2010;107:1235–7.
[37] Benna P, Colonna R, Montalenti E. Takotsubo cardiomyopathy induced by
epileptic seizures: a case-report. Poster presented at the 9th Congress on
Epileptology. Epilepsia 2010;51:67.
[38] van Rijckevorsel K, Dupuis M, Evrard F. Takotsubo syndrome (TKS) in epilepsy:
a possible mechanism of sudep? Epilepsia 2010;51:67.121 [see Benna].
[39] Montepietra S, Cattaneo L, Granella F, Maurizio A, Sasso E, Pavesi G, et al.
Myocardial infarction following convulsive and nonconvulsive seizures. Sei-
zure 2009;18:379–81.
[40] Espinosa PS, Lee JW, Tedrow UB, Bromﬁeld EB, Dworetzky BA. Sudden unex-
pected near death in epilepsy: malignant arrhythmia from a partial seizure.
Neurology 2009;72:1702–3.
[41] Kalra N, Khetpal P, Sorrell VL. Seriously stressed. Am J Med 2009;122:735–7.
[42] Kurisu S, Inoue I, Kawagoe T, et al. Prevalence of incidental coronary artery
disease in tako-tsubo cardiomyopathy. Coron Artery Dis 2009;20:214–8.
[43] Sto¨llberger C, Huber JO, Enzelsberger B, Finsterer J. Fatal outcome of epileptic
seizure-induced takotsubo syndrome with left ventricular rupture. Eur J
Neurol 2009;16:e116–7.
[44] Schiano P, Barbou F, Lallali M, Hemery Y, Revel F, Monse´gu J. Ballonisation
me´dioventriculaire au cours d’un syndrome de sevrage me´dicamenteux.
Presse Med 2009;38:1374–7.
[45] Ramı´rez-Moreno JM, Bejarano-Moguer V, Elduayen J, Milla´n-Nu´n˜ez MV, Pons-
Garcı´a MA, Go´mez MJ, et al. Ischemic stroke due to transient left ventricular
apical ballooning in women with epilepsy debut. Rev Neurol 2009;48:333–5.
[46] Vidi V, Rajesh V, Singh PP, Mukherjee JT, Lago RM, Venesy DM, et al. Clinical
characteristics of tako-tsubo cardiomyopathy. Am J Cardiol 2009;104:578–82.
[47] Yousuf MA, Adjei S, Kinder B. A 58-year-old woman with ST-segment eleva-
tion, seizures, and altered mental status in the setting of opiate withdrawal.
Chest 2009;135:1098–101.[48] Fugate JE, Wijdicks EF, Kumar G, Rabinstein AA. One thing leads to another:
GBS complicated by PRES and Takotsubo cardiomyopathy. Neurocrit Care
2009;11:395–7.
[49] Nielsen LH, Munk K, Goetzsche O, Christiansen EH, Nørgaard BL. Takotsubo
cardiomyopathy. An important differential diagnosis to acute myocardial
infarction. Dan Med Bull 2009;56:165–8.
[50] Littlejohn FC, Syed O, Ornstein E, Connolly ES, Heyer EJ. Takotsubo cardio-
myopathy associated with anesthesia: three case reports. Cases J
2008;1:227.
[51] El Mahmoud R, Mansencal N, Pillie´re R, Leyer F, Abbou N, Michaud P, et al.
Prevalence and characteristics of left ventricular outﬂow tract obstruction in
Tako-Tsubo syndrome. Am Heart J 2008;156:543–8.
[52] Lim BA. Tako Tsubo cardiomyopathy in a patient with antiphosholipid syn-
drome secondary to systemic lupus erythemathosus (SLE). Med J Malaysia
2008;63:146–7.
[53] Legriel S, Bruneel F, Dalle L, Appere-de-Vecchi C, Georges JL, Abbosh N, et al.
Recurrent takotsubo cardiomyopathy triggered by convulsive status epilepti-
cus. Neurocrit Care 2008;9:118–21.
[54] Seow SC, Lee YP, Teo SG, Hong EC, Lee CH. Takotsubo cardiomyopathy
associated with status epilepticus. Eur J Neurol 2008;15:e46.
[55] Shimizu M, Kagawa A, Takano T, Masai H, Miwa Y. Neurogenic stunned
myocardium associated with status epileptics and postictal catecholamine
surge. Intern Med 2008;47:269–73.
[56] Banuelos PA, Temes R, Lee VH. Neurogenic stunned myocardium associated
with reversible posterior leukoencephalopathy syndrome. Neurocrit Care
2008;9:108–11.
[57] Bosca ME, Valero C, Pareja AI, Bonet M, Bosca I, Sanchez-Roy R, et al. Tako-
tsubo cardiomyopathy and status epilepticus: a case report. Eur J Neurol
2008;15:e34–5.
[58] Weeks SG, Alvarez N, Pillay N, Bell RB. Tako tsubo cardiomyopathy secondary
to seizures. Can J Neurol Sci 2007;34:105–7.
[59] Worthley MI, Anderson TJ. Transient left ventricular apical ballooning syn-
drome following a hyponatraemic seizure. Int J Cardiol 2007;115:e102–4.
[60] Sakuragi S, Tokunaga N, Okawa K, Kakishita M, Ohe T. A case of takotsubo
cardiomyopathy associated with epileptic seizure: reversible left ventricular
wall motion abnormality and ST-segment elevation. Heart Vessels
2007;22:59–63.
[61] Mitchell SA, Crone RA. Takotsubo cardiomyopathy: a case report. J Am Soc
Echocardiogr 2006;19. 1190.e9–10.
[62] Parvulescu-Codrea S, Britton JW, Bruce CJ, Cascino GD, Jaffe AS. Elevations of
troponin in patients with epileptic seizures? What do they mean? Clin Cardiol
2006;29:325–6.
[63] Ennezat PV, Pesenti-Rossi D, Aubert JM, et al. Transient left ventricular basal
dysfunction without coronary stenosis in acute cerebral disorders: a novel
heart syndrome (inverted Takotsubo). Echocardiography 2005;22:599–602.
[64] Sharkey SW, Lesser JR, Zenovich AG, et al. Acute and reversible cardiomyopa-
thy provoked by stress in women from the United States. Circulation
2005;111:472–9.
